Poolbeg Pharma voluntarily delists ordinary shares from OTCQB due to low trading volume.

Poolbeg Pharma PLC, a UK biopharmaceutical firm, voluntarily delists ordinary shares from OTCQB due to low trading volume, retaining listing on London Stock Exchange's AIM Market with ticker "POLB." The company continues its focus on innovative medicines for high unmet medical needs, including rare and orphan diseases. Poolbeg aims to list on a U.S. national securities exchange like Nasdaq when appropriate.

July 26, 2024
3 Articles